Home/Filings/4/0001144204-12-007338
4//SEC Filing

Maslan Andrew Scott 4

Accession 0001144204-12-007338

CIK 0001091596other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 4:58 PM ET

Size

6.4 KB

Accession

0001144204-12-007338

Insider Transaction Report

Form 4
Period: 2012-02-08
Maslan Andrew Scott
Chief Financial Officer
Transactions
  • Conversion

    Common Stock

    2012-02-08+17,92287,819 total
  • Other

    Common Stock

    2012-02-08+1,00088,819 total
Footnotes (2)
  • [F1]The reporting person converted his shares of the Series D Convertible Preferred Stock at a conversion price of $0.558 per share.
  • [F2]Represents shares of stock dividend on the Series D Convertible Preferred Stock.

Issuer

CYTOMEDIX INC

CIK 0001091596

Entity typeother

Related Parties

1
  • filerCIK 0001332669

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:58 PM ET
Size
6.4 KB